RIP-1

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF
- EP 4157835 A1
  申请人: SANOFI SA优先权: 2020
  CN
  EP
  US
  WO
  5 件公开
- US 11897876 B2
  申请人: GENZYME CORP优先权: 2021
  CN
  US
  3 件公开
Treating hyperinsulinemia by killing beta cells with cytotoxic gene
US 2005137157 A1申请人: CHARLES F BRUNICARDI M D优先权: 2000
US
4 件公开
Modulators of regulatory proteins
US 7101675 B2申请人: YEDA RES & DEV优先权: 2002
US
3 件公开
RAPID SPECIFIC PATHOGEN FREE ANIMAL
US 2015173333 A1申请人: BIOVALENCE SDN BHD优先权: 2012
CN
US
2 件公开
Bicyclic compound as RIP-1 kinase inhibitor and application thereof
US 12351587 B2申请人: MEDSHINE DISCOVERY INC优先权: 2019
CN
US
2 件公开
HETEROCYCLIC RIP1 KINASE INHIBITORS
WO 2022192533 A1申请人: RIGEL PHARMACEUTICALS INC优先权: 2021
CN
WO
2 件公开
RECOMBINANT IMMUNOTOXIN COMPRISING A RIBOSOME INACTIVATING PROTEIN
US 20250387478 A1申请人: ATB THERAPEUTICS优先权: 2022
CN
US
2 件公开
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
EP 4248975 A3申请人: RIGEL PHARMACEUTICALS INC优先权: 2018
EP
2 件公开
Modulation of Programmed Necrosis
US 2008019909 A1申请人: CHAN FRANCIS KA-MING优先权: 2004
US
Balsm-pear-seed ribosome inactivated protein and its coding gene and use
CN 101070342 B申请人: SHANXI KANGBAO BIOLOG PRODUCTS CO LTD优先权: 2007
CN